Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

The Antidote to the Clinical Trial Bottleneck

Posted by hunter@stemsave.com on Feb 10, 2018 3:21:00 PM

Read More

Topics: clinical trials, Phase I/II clinical trials, FDA approval

Stem Cell Graft Receives FDA Approval

Posted by pamela@stemsave.com on Jan 29, 2018 11:58:31 AM

images.jpg

The FDA has approved a novel synthetic scaffold that would allow stem cells to regrow bone more efficiently. The proprietary technology, Osteo-P [from Molecular Matrix Inc.], replaces the use of bone grafts and utilizes the patient’s own stem cells to regrow bone following trauma or injury. The Osteo-P, a scaffold made of carbohydrate [sugar] polymer, is an improved alternative to current bone grafting procedures in that it enables the body’s own stem cells to regenerate bone in aggregate, and it is resorbed by the body as it is replaced by the newly formed bone.

Read More

Topics: bone regeneration, FDA approval, stem cell graft

Combatting Alzheimer’s Disease with Stem Cells

Posted by pamela@stemsave.com on Jun 28, 2017 1:45:00 PM

Biostar Stem Cell Research institute has developed a protocol  for the use of autologous [the patient’s own] stem cells to combat Alzheimer’s Disease with the FDA has approving Phase I and II clinicals trials for the new treatment. The process involves recovering, isolating and culturing the patient’s own stem cells. Culturing the cells results in the production of a clinically significant number of cells, enabling an extended treatment period and protocol. These cells are injected intravenously across ten treatments, using approximately 200 million cells each time. By utilizing the patient’s own stem cells to address neural degradation, the researchers anticipate the treatment may go a long way to both slow the degenerative progression of the disease, while also addressing the root cause of Alzheimer’s Disease.

Read More

Topics: Alzheimer's disease, Phase I/II clinical trials, FDA approval, regenrative medicine

Texas Legislators Give Boost to Stem Cell Treatments

Posted by taylor@stemsave.com on Jun 22, 2017 1:00:00 PM

The Texas legislature has just passed House Bill 810, allowing chronically or terminally ill patients access to adult stem cell treatments that are currently in clinical trials but are not yet approved by the FDA. Hence, potentially successful treatments may now be accessed by patients who have exhausted all other measures of treatment, but whose time will have run out by the time these treatments receive approval.

 

Read More

Topics: stem cell treatments, regenerative medicine, FDA approval

Accelerating Stem Cell Therapies

Posted by hunter@stemsave.com on Oct 27, 2016 5:22:53 PM

The California Institute of Regenerative Medicine announced a $30 million initiative to advance stem cell therapies. The program is designed to facilitate research’s move from bench to bedside – accelerating clinical trials and laying the groundwork for FDA approval.

Read More

Topics: stem cell therapies, clinical trials, regenerative medicine, autologous stem cells, FDA approval

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Recent Posts

Posts by Topic

see all